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Abstract 
Background and Aims: Recently, a novel DNA virus was isolated from the serum of a 
patient with post-transfusion non A-G hepatitis and named TT virus. The aim of this study 
was to determine the prevalence TT virus among cirrhotic patients due to hepatitis B & C in 
infection Ahwaz. 
Methods: The prevalence of TTV infection was studied in 41 patients with liver cirrhosis. 
TTV DNA was detected by semi-nested PCR. The plasma samples were tested for marker 
hepatitis B & C by ELISA test. 
Results: TT virus was detected in 17(41.46%) of the 41 patients with cirrhotic liver disease. 
There were no significant difference between the subject TTV DNA in relation to sex and 
age. TTV positivity in cirrhotic patient infected with hepatitis B (52.9%) was higher than in 
similar patients infected with hepatitis C (47.1%). 
Conclusion: TTV infection was highly prevalence in patient with cirrhotic hepatitis, 
especially in those with hepatitis B virus infection. 
Keywords: Transfusion Transmitted Virus; hepatitis B virus; hepatitis C virus; Liver 
cirrhosis 
Introduction 
 
ases of hepatitis that are acute and 
chronic have been identified caused by 
agent serologically and genomically 
distinct from the hepatitis viruses A, B, C, D, 
and E (1). Most patients with fulminant 
hepatitis are without the typical markers of 
hepatitis viral infection (2, 3). These findings 
strongly suggest the existence of additional 
hepatitis viruses. In 1995, GB virus C/hepatitis 
G virus (GBV-C/HGV) was found as a 
candidate for a new hepatitis virus (4, 5). 
Although GBV-C/HGV was first reported to 
be associated with fulminant hepatitis of 
unknown etiology, many subsequent reports 
have suggested no or limited pathogenicity of 
GBV-C/HGV as a hepatitis virus (6). 
In 1997, a novel DNA virus, designated as the 
TT virus was cloned by representational 
difference analysis from an acute phase serum 
of a patient with post transfusion hepatitis of 
unknown etiology (7). The virus could be 
isolated from tree of five Japanese patients 
with post-transfusion non A to G hepatitis, and 
has come to be regcorded as a ״transfusion-
transmitted virus״. TTV is an unenveloped 
negative circular single-stranded DNA virus 
and comprises 3.852 nucleotides, with an 
isopycnic density of 1.31 to 1.34 g/ml in CsCl 
(8, 9). 
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The analysis of several open reading frames 
(ORFs) suggested that TTV is a member of the 
Circoviridae family (9). The clinical 
implication of TTV infection remain largely 
unresolved and its epidemiology is unknown 
(10).  
The aim of this study was to determine patients 
due to Hepatitis B and C infection in few 
hospitals in Ahwaz.  
 
Methods 
 
Patients 
From September 2004 to September 2005, 
plasma samples were collected from 41 
cirrhotic patients (29 male, 12 female) who 
visited the Imam   
Khomaini hospital of Ahwaz (Table1). Plasma 
samples were taken on admission from all 
patients. Plasma samples for PCR were 
aliquoted and stored -80ºC until analysis. 
follow up samples were also collected from 
those patients who were positive TTV DNA. 
Serological tests 
Type-specific diagnosis of Hepatitis viruses 
from cirrhotic patients was made by testing for 
the following hepatitis viral markers: hepatitis 
B surface antigens (Diaplas Inc), IgM 
antibodies to hepatitis B core antigen 
(Microwell ELISA), HBe Ag/Ab (DIA.PRO), 
HCV antibodies (Diaplas Inc), the samples 
were tested by the ELISA method. 
Detection of TTV DNA 
DNA was extracted from 200µl samples using 
a high pure viral nucleic acid kit (Roche, 
Germany) and was resuspended in 50µl elution 
buffer. TTV DNA was amplified by semi-
nested PCR with TTVspecific primers derived 
from two conserved region of the published 
sequences (11). For the first  
 around 0.5µl primer A (sense primer NG059: 
5′-ACA GAC AGA GGA GAA GGC AAC 
ATG-3′) 0.5µl of primer B (antisense primer 
NG063: 5′-CTG GCA TTT TAC CAT TTC 
CAA AGT T-3′) were used in 25µl PCR 
mixture containing: 2.5µl 10xPCR buffer, 
0.5µl dNTPs, 5µl template, 0.2µl  Taq DNA 
polymerase, 15.8µl PCR water. The 
amplification was for 35 cycles at 94 ºC for 
30s, 60ºC for 30s and 72ºC for 45s, followed 
by 7min at 72ºC. In the second round with 
another sensepatients by hepatitis B and in 
group TTV-positive with cirrhotic patients by 
hepatitis C. primer C (NG061: 5′-GGC AAC 
ATG TTA TGG ATA GAC TGG-3′) and the 
same antisense primer B were used. The 
second round of PCR was performed for 25 
cycles under the same time temperature 
conditions using 2µl of the first round PCR 
products as template. The PCR products 
(271bp) were electrophoresed in 2% agarose 
gel, stained with ethidium bromide, and 
photographed under ultraviolet light. Positive 
samples (blood transfusion center Tehran- 
Iran) and negative controls were included in 
each run. DNA 100bp ladder was used as DNA 
molecular weight size marker.  
Statistical analysis 
Statistical analysis was conducted using the 
Chi-square test. P-values of less than 0.05 were 
considered to be significant. 
 
Results 
Table 1: TTV seroprevalence among individuals 
TTV DNA 
Positive (%) n 
Patient 
features 
  Gender 
10 29 Male 
7 12 Female 
  Age (years) 
1(50%) 2 20-29 
0 (0%) 0 30-39 
1(12.5%) 8 40-49 
10 (45.45%) 22 50-59 
5 (55.5%) 9 60-69 
17 (39.5%) 43 Total 
 
Table  2: TTV DNA in sera of patients with 
cirrhotic liver disease 
 
TTV DNA 
Positive (M/F) Sex(M/F) Backgrounds
9 (4/5) 22/9 Any HBV marker* 
8 (6/2) 7/3 HCV antibody 
* Any HBV marker includes HBs antigen, HBc 
antibody, HBe Ag/Ab 
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Fig. 1: Positive TTV tested samples (molecular 
size 271bp) confirmed by semi nested PCR 
metho
 Presence of TTV DNA in cirrhotic hepatitis 
patients TTV DNA was detected in 17 of 41 
patients (41.46%) with cirrhotic hepatitis 
(Fig1). d.    
  TTV positivity in cirrhotic patients than with 
hepatitis B (52.9%) was higher in cirrhotic 
patients (47.1%) with hepatitis C infection 
(Table 2). 
The sex distribution was not significantly 
different in TTV-positive individuals with 
infected hepatitis B and hepatitis C viruses. 
The age distribution was not significantly 
ifference in group TTV-positive with cirrhotic   
patients by hepatitis B and in group TTV-
positive with cirrhotic patients by hepatitis C. 
 
Discussion 
 
 A new DNA virus named TTV was recently 
identified in Japan in the serum of patients 
with posttransfusion non A-G hepatitis. TTV 
was detected in 41.46% of cirrhotic patient 
from Ahwaz city in Iran. The prevalence of 
TTV infection among cirrhotic patient in other 
countries has been reported to be 10% in the 
Korea (12), 66.7% in Japan (13), 63% in 
Taiwan (14). These differences in prevalence 
between countries could be due to the different 
geographical distribution of TTV infection, 
and the heterogeneity and variability of TTV 
isolates (11, 15). Variation could also arise due 
to different experimental methods to determine 
TTV infection, such as the primers used, and 
the sensitivity of the PCR methods employed 
(16, 17). The primers used in our study was 
identical to that used in the aforementioned 
countries, suggesting that the discrepancies of 
TTV prevalence between countries were not 
due to variation in the primer used. 
Table 1 shows the TTV seroprevalence of 
subgroups of patients when these were divided 
by gender and age. There were no significant 
differences between TTV DNA in relation to 
sex. Vasconcelos et al. have reported similar 
finding (18), which were confirmed by Sioda 
et al (13). 
With respect to age, the frequency of TTV 
infection was relatively high at the age of 50-
59, but our results showed no difference 
between age distribution and TTV positive. 
Which are in agreement  with results reported 
by Gad et al (19). 
In conclusion TTV infection was highly 
prevalence in patient with cirrhotic hepatitis, 
especially in patients with hepatitis B. 
TTV viremia is widespread with a very high 
incidence in general population worldwide. 
This suggests that TTV is a common virus and 
may be a nonpathogenic DNA virus in 
humans, although the pathogenic roles of TTV 
still remain to be investigated. 
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